Q-Line Biotech (NSE:QLINE) Common Stock: ₹16 Mil (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Common Stock?

Q-Line Biotech NSE:QLINE -5.15% 12 Common Stock is ₹16 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's quarterly common stock stayed the same from Mar. 2023 (₹16 Mil) to Mar. 2024 (₹16 Mil) and stayed the same from Mar. 2024 (₹16 Mil) to Mar. 2025 (₹16 Mil).

Q-Line Biotech's annual common stock stayed the same from Mar. 2023 (₹16 Mil) to Mar. 2024 (₹16 Mil) and stayed the same from Mar. 2024 (₹16 Mil) to Mar. 2025 (₹16 Mil).

Q-Line Biotech Common Stock Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Common Stock Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Common Stock
15.75 15.75 15.75

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Common Stock 15.75 15.75 15.75
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹16 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Common Stock of ₹16 Mil as of Mar. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Common Stock too high?
Q-Line Biotech's current Common Stock is ₹16 Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Common Stock compare to ABT and SYK?
Q-Line Biotech's Common Stock of ₹16 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Common Stock is ₹16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Common Stock of ₹16 Mil. The current Common Stock is ₹16 Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Common Stock is ₹16 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price